Northern Trust
LEGN icon

Northern Trust’s Legend Biotech LEGN Stock Holding History

Northern Trust’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.94M Sell
274,856
-5,370
-2% -$145K ﹤0.01% 2338
2026
Q1 		$5.07M Buy
280,226
+4,107
+1% +$78.3K ﹤0.01% 2451
2025
Q4 		$6M Sell
276,119
-10,982
-4% -$315K ﹤0.01% 2367
2025
Q3 		$9.36M Buy
287,101
+31,720
+12% +$1.17M ﹤0.01% 2155
2025
Q2 		$9.06M Sell
255,381
-31,240
-11% -$1.01M ﹤0.01% 2131
2025
Q1 		$9.73M Buy
286,621
+1,943
+0.7% +$69.7K ﹤0.01% 2051
2024
Q4 		$9.26M Buy
284,678
+200,786
+239% +$8.32M ﹤0.01% 2175
2024
Q3 		$4.09M Sell
83,892
-20
-0% -$1.06K ﹤0.01% 2593
2024
Q2 		$3.72M Sell
83,912
-4
-0% -$185 ﹤0.01% 2559
2024
Q1 		$4.71M Buy
83,916
+1,440
+2% +$86.8K ﹤0.01% 2499
2023
Q4 		$4.96M Sell
82,476
-59,421
-42% -$3.77M ﹤0.01% 2524
2023
Q3 		$9.53M Sell
141,897
-2,261
-2% -$157K ﹤0.01% 2040
2023
Q2 		$9.95M Sell
144,158
-31,759
-18% -$2.08M ﹤0.01% 2068
2023
Q1 		$8.48M Buy
175,917
+66,224
+60% +$3.24M ﹤0.01% 2131
2022
Q4 		$5.48M Buy
109,693
+789
+0.7% +$38.2K ﹤0.01% 2427
2022
Q3 		$4.44M Buy
108,904
+5,549
+5% +$260K ﹤0.01% 2560
2022
Q2 		$5.68M Buy
103,355
+8,812
+9% +$372K ﹤0.01% 2423
2022
Q1 		$3.44M Buy
+94,543
New +$3.74M ﹤0.01% 2801

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Northern Trust's LEGN Position: Q2 2026 in Review

Northern Trust reduced its Legend Biotech (LEGN) stake by 1.9% in Q2 2026, selling an estimated $145K and leaving 274,856 shares worth $7.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

Northern Trust first reported a position in LEGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.95M in Q2 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Northern Trust held 274,856 shares of Legend Biotech worth $7.94M as of Q2 2026.
  • Northern Trust sold 5,370 Legend Biotech shares in Q2 2026, an estimated $145K.
  • Legend Biotech made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2338 holding.
  • Northern Trust first reported a position in Legend Biotech in Q1 2022 and has held it in 18 quarters since.
  • Northern Trust's Legend Biotech position peaked at $9.95M in Q2 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.